CE mark for overactive bladder neuromodulation device

StimGuard has received a CE mark for a wireless neuromodulation device to treat chronic symptoms of overactive bladder. “A wireless system that enables urologists to...
Medtronic logo

Medtronic receives FDA Approval for deep brain stimulation therapy for medically refractory epilepsy

The US Food and Drug Administration (FDA) has granted premarket approval for Medtronic's deep brain stimulation (DBS) therapy as adjunctive treatment for reducing the...

Spinal cord stimulation and chronic pain: In the end it’s about the patient

Krishnan Chakravarthy writes in NeuroNews about how spinal cord stimulation can be used to treat chronic pain and how this can help America overcome...

Axonics secures US$40M financing to commercialise neuromodulation device

Axonics has secured US$40 million to support commercialisation of its neuromodulatory treatment of urinary and bowel dysfunction. The financing comes as Axonics closes in on the...

Simon Thomson

Laurent Pierot

Joshua A Hirsch

(Visited 2,167 times, 3 visits today)